Indomethacin. In: ReillyMJ, ed. American hospital formulary service. Washington, DC: American Society of Hospital Pharmacists, 1970: Section 28:08.
2.
KellyM.Indomethacin, remarkable antirheumatic drug. Med J Aust1964; 2: 541–4.
3.
BarnesCGGoodmanHVEadeAWT, A double blind comparison of naproxen with indomethacin in osteoarthritis. J Clin Pharmacol1975; 15: 347–54.
4.
DeGraffR.A double blind comparative study of niflumic acid and indomethacin in elderly patients with osteoarthritis of the knee and/or hip. Medikon1974; 3: 19–24.
5.
BainLSGallowayDBPetrieJC, Gout. Br Med J1974; 1: 446–8.
6.
WoodburyDMFinglE.Analgesic-antipyretics, antiinflammatory agents, and drugs employed in the therapy of gout. In: GoodmanLSGilmanA, eds. The pharmacological basis of therapeutics. New York: MacMillan, 1975: 341–2.
7.
ClaymanCB, The prostaglandins. JAMA1975; 233: 904–6.
8.
McGiffJC, Banter's syndrome results from an imbalance of vasoactive hormones. Ann Intern Med1977; 87: 369–72.
9.
DonkerAJMDejongPEVan EpsLW StatiusIndomethacin in Banter's syndrome. Nephron1977; 19: 200–13.
10.
HaluskaPVWohltmannPPriviteraPJ, Banter's syndrome, urinary prostaglandin E-like material, and kallikrein; indomethacin effects. Ann Intern Med1977; 87: 281–6.
11.
FichmanMPTelferPAZiaPA, Role of prostaglandins in the pathogenesis of Banter's syndrome. Am J Med1976; 60: 785–97.
12.
RumpfKWFrenzelSLowetzHD, The effect of indomethacin on plasma renin activity in man under normal conditions and after stimulation of the renin-angiotension system. Prostaglandins1975; 10: 641–8.
13.
FröhlichJCHollifieldJWWilsonJP, Suppression of plasma renin activity by indomethacin: Independence of sodium retention. Clin Res1976; 24: 271A.
14.
PatakRVMookerjeeBKBentzelCJ, Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins1975; 10: 649–59.
15.
KimberlyRPBowdenREKeiserHR, Reduction in renal function by newer nonsteroidal antiinflammatory drugs. Am J Med1978; 64: 804–7.
